ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on Cabozantinib in Advanced RCC After the Failure of CPI Therapy: Final Analysis of a Non-Interventional CaboCHECK Study
By
ASCO Genitourinary Cancers Symposium
FEATURING
Viktor Grünwald
By
ASCO Genitourinary Cancers Symposium
FEATURING
Viktor Grünwald
Login to view comments.
Click here to Login